ROIV

Roivant Sciences Ltd.

CIK 0001635088 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations

$36.81

↑ 0.72 (2.00%)

as of Jul 9, 2026

End-of-day close, not real-time intraday

Live price (Google Finance) ↗

Overall read: NeutralOverall score · based on 4/4 lenses

FundamentalsOwnershipTechnicalsOptions

Bullish: Technicals; Risks: Fundamentals

Key stats

Market Cap

$25.96B

P/E Ratio

-66.83

EPS

-0.43

Dividend Yield

Not covered

52W Position

101%

Beta

1.05

Valuation multiples

Fwd P/E

Not covered

PEG

Not covered

P/B

4.90

P/S

3,142.67

EV/Revenue

2,970.85

ROE

-5.7%

Valuation data covers 8,502/9,463 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 101%

$10.71$36.63

Latest Financials

2026-03-31 FY

Revenue

$8.26M

Net Income

-$299.77M

Total Assets

$5.71B

Free Cash Flow

-$758.56M

ROIV

Key stats

Valuation multiples

Price · 1Y

Latest Financials

Recent news

ROIV

Key stats

Valuation multiples

Price · 1Y

Latest Financials

Recent news